A/Prof Howard Gurney

A/Prof Howard Gurney is a renowned oncologist with expertise in the field of cancer research and treatment. Based in Sydney, Australia, he currently holds the position of Director of Medical Oncology for Cancer Services at Western Sydney Area Health Service. He is actively involved in supervising the delivery of high-quality medical care to patients suffering from various types of cancer.

A/Prof Gurney completed his Bachelor of Medicine and Bachelor of Surgery degree with honors from the University of New South Wales in 1981. He later became a Fellow of the Royal Australasian College of Physicians in 1988. With over three decades of experience, he has established himself as one of the leading oncologists in Western Sydney.

In addition to his clinical practice, A/Prof Gurney dedicates his time to cutting-edge research in oncology. He serves as the head of the Clinical Trials Unit in medical oncology at Westmead Hospital, where he plays a key role in advancing cancer research and exploring new treatment options. His commitment to research has not only contributed to the development of novel cancer therapies but has also brought hope to countless patients.

A compassionate and dedicated physician, A/Prof Gurney works closely with each patient to provide personalized and comprehensive care. He specialises in the treatment of lymphomas and genitourinary cancers, specifically prostate, bladder, and kidney cancers. His expertise and unwavering commitment to the well-being of his patients make him highly sought-after and respected within the medical community.

A/Prof Gurney is available for consultation at Norwest Private, Blacktown, and Westmead Public Hospitals. He strives to provide his patients with the highest standard of care, ensuring they receive the best possible treatment options and support throughout their cancer journey.

With numerous accolades and recognition to his credit, A/Prof Howard Gurney is a true inspiration and asset to the medical community. His outstanding contributions to the field of oncology and his genuine commitment to improving patient outcomes make him a highly regarded figure in the medical fraternity.